RA Capital’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

RA Capital Management is a venture capital firm that invests in healthcare and life-sciences companies. Read more

Peter Kolchinsky's photo - Managing Partner of RA Capital

Managing Partner

Peter Kolchinsky

CEO Approval Rating

68/100

Est. Annual Revenue
Est. Employees
Sector

Update Industry

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Longitude Capital is a top competitor of RA Capital. Longitude Capital was founded in 2006, and is headquartered in Menlo Park, California. Longitude Capital is in the Investment Banking & Brokerage industry. Longitude Capital generates $3.4M less revenue vs. RA Capital.

H.I.G. Capital is seen as one of RA Capital's top competitors. H.I.G. Capital is headquartered in Miami, Florida, and was founded in 1993. H.I.G. Capital is in the Mortgage Finance field. H.I.G. Capital generates 6,944% the revenue of RA Capital.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is TPG Capital a competitor of RA Capital?

Acquisitions

No recent acquisitions found related to RA Capital

RA Capital Funding History

$300M

Since RA Capital was founded in 01/2001, it has participated in 1 round of funding. In total RA Capital has raised $300.0M. RA Capital's funding round was on Jul 2019 for a total of $300.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Investment Fund
Jul 2019
$300M
-

Total Funding: $300M

Since RA Capital was founded in 01/2001, it has participated in 1 round of funding. In total RA Capital has raised $300.0M. RA Capital's funding round was on Jul 2019 for a total of $300.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Silverback is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and fibrosis.
$85M
Sep 22, 2020
Series C
-
Synthego develops a machine learning-based platform that offers genome engineering solutions for researchers.
$100M
Aug 25, 2020
Series D
-
Freenome is a biotechnology company that develops a multiomics platform for early detection of cancer.
$270M
Aug 25, 2020
Series C
-
Connect Biopharmaceuticals is a clinical-stage company that develops immune modulators for the treatment of autoimmune and inflammatory diseases.
$115M
Aug 23, 2020
Series C
-
Aerovate Therapeutics is a biotechnology company that develops and commercializes novel therapeutics for the treatment of cardiopulmonary diseases.
$72.6M
Aug 05, 2020
Series A
-

RA Capital News

August 27, 2020FinSMEs

Synthego Raises $100M in Series D Funding

Synthego, a Redwood City, Calif.-based genome engineering company, raised $100m in Series D financing... See more »
August 26, 2020BioSpace

Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand

Synthego, the genome engineering company, today announced that it raised $100 million in a Series D f... See more »
August 26, 2020Asian Venture Capital Journal

RA Capital leads round for China's Connect Biopharma

Connect Biopharma, a drug developer based in China and the US, has raised $115 million in Series C fu... See more »
August 26, 2020Xconomy

Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies

Drugs designed to precisely target cancers with specific genetic signatures have changed the course o... See more »
August 24, 2020FinSMEs

Connect Biopharma Closes $115M Series C Financing

Connect Biopharma, a San Diego, CA- and Taicang,...... See more »
August 10, 2020Pharamceutical Technology

Verona raises $200m in a private placement

Chronic obstructive pulmonary disease (COPD) specialist Verona Pharma has closed an oversubscribed pr... See more »
August 7, 2020VC News Daily

Aerovate Therapeutics Inks $72.6M Series A

BOSTON, MA, Aerovate Therapeutics has closed on $72.6 million in Series A funding.... See more »

RA Capital Press Releases

April 12, 2019Business Wire

Atlas Venture, F-Prime Capital, RA Capital Management, and Osage University Partners to Host Second Annual Science2Startup Symposium

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Science2Startup Symposium occurs in Cambridge on April 23, 201... See more »
April 2, 2018StreetInsider

RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals

BOSTON, April 2, 2018 /PRNewswire/ -- RA Capital Management, LLC ("RA Capital") today announced that ... See more »
September 22, 2017Business Press 24

Realm Therapeutics Announces $26 Million PIPE Financing

MALVERN, PA -- (Marketwired) -- 09/21/17 -- (AIM: RLM), a clinical stage biopharmaceutical company fo... See more »
March 30, 2017Blackbird

Solid Biosciences Raises up to $50 Million in Series C Financing

CAMBRIDGE, Mass.-(BUSINESS WIRE)-Solid Biosciences announced today that it has completed the initial ... See more »
May 19, 2014CNW

Coherus BioSciences Secures $55 million Series C Financing

REDWOOD CITY, Calif., May 19, 2014 /CNW/ - Coherus BioSciences, Inc. ("Coherus"), a leading biologics... See more »
March 13, 2014BUSINESS WIRE

pSivida Corp. Announces $7.0 Million Investment by RA Capital

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces $7 million investment by RA Capital... See more »

Headquarters

20 Park Plz Suite 1200

Boston, Massachusetts02116

617-778-2509

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

RA Capital Management is a venture capital firm that invests in healthcare and life-sciences companies. RA Capital was founded in 01/2001. RA Capital's headquarters is located in Boston, Massachusetts, USA 02116. It has raised 300.0M in 1 round. The l...

CEO

RA Capital's Managing Partner, Peter Kolchinsky, currently has an approval rating of 68%. RA Capital's primary competitors are Longitude Capital, H.I.G. Capital & Collerip.

Website

racap.com

Frequently Asked Questions about RA Capital

  1. When was RA Capital founded?

    RA Capital was founded in 01/2001
  2. Who is RA Capital's CEO?

    RA Capital's CEO is Peter Kolchinsky
  3. How much revenue does RA Capital generate?

    RA Capital generates $7.4M in revenue
  4. How much funding does RA Capital have?

    RA Capital has historically raised $300M in funding
  1. Where is RA Capital's headquarters?

    RA Capital's headquarters is in Boston Massachusetts, USA
  2. How many employees does RA Capital have?

    RA Capital has 10 employees
  3. Who are RA Capital's competitors?

    RA Capital's top competitors are Longitude Capital, H.I.G. Capital, Collerip
  4. Who has RA Capital invested in?

    RA Capital's has invested in companies such as Silverback, Synthego, Freenome